Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
APLS Apellis Pharmaceuticals Inc
AMD Advanced Micro Devices Inc
OTIS Otis Worldwide Corp
GME GameStop Corp
ECF Ellsworth Growth and Income Fund Ltd
SILK Silk Road Medical Inc
HLVX Hillevax Inc
AIZ Assurant Inc
NOTV Inotiv Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Premarket

Last Trade
Delayed
$246.21
-0.20 (-0.08%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$246.41
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
91

10-day average volume:
2,532,087
91

Upcoming Events

AMGN's fiscal year ends in December
    • FEB
      14
      2023
    • Ex-dividend Date
    • Dividend amount
      $2.13
    • Record date
      February 15, 2023
    • Pay date
      March 8, 2023

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
January 31, 2023Q4 2022 Earnings Release$4.09$3.94 to $4.25$4.36
November 3, 2022Q3 2022 Earnings Release$4.70$4.23 to $4.75$4.67
August 4, 2022Q2 2022 Earnings Release$4.65$3.95 to $4.87$4.38
April 27, 2022Q1 2022 Earnings Release$4.25$3.70 to $4.67$3.70
February 7, 2022Q4 2021 Earnings Release$4.36$3.66 to $5.08--

Past Dividends

Ex-dividend dateAmountRecord datePay date
November 16, 2022$1.94November 17, 2022December 8, 2022
August 17, 2022$1.94August 18, 2022September 8, 2022
May 16, 2022$1.94May 17, 2022June 8, 2022
February 14, 2022$1.94February 15, 2022March 8, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.